Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
5/23/2007
 
First Published:
4/23/2003
1.
Phase I/II Study of MDX-060 Monoclonal Antibody in Patients With Refractory or Relapsed CD30-Positive Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
Over 12
NCI, Pharmaceutical / Industry
MSKCC-02121
MDX-060-01, NCT00059995
2.
Study of the Combination of MDX-060 With Gemcitabine, MDX-060 Combined With Dexamethasone, and Gemcitabine Alone in Hodgkin's Disease
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
12 and over
Pharmaceutical / Industry
MDX060-05
NCT00284804
3.
MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
12 and over
Pharmaceutical / Industry
MDX060-04
NCT00298467
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute